Fact CheckerSign in

NCT07629349Recruiting

Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression

Source: ClinicalTrials.gov · Last updated 5 Jun 2026

Brief summary (registry, in English)

The goal of this observational study is to improve the detection of dementia with Lewy bodies (DLB) and its prodromal phases, as well as advancing our current understanding of biological mechanisms and therapeutic options. The data is acquired at cognitive clinics in Stockholm (Sweden) and combined with national and international data to increase statistical power, representativeness and replication of results. Participants undergo collection of clinical assessments, neuroimaging and fluid biomarkers.

Status (registry)
Recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
22 Apr 2026
Start date
1 Jan 2020
Primary completion date
1 Mar 2031
Lead sponsor
Karolinska Institutet
NCT number
NCT07629349

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From 1 Jan 2020 to the primary completion date, 1 Mar 2031
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Causes of cognitive impairment other than those related to dementia or MCI. Current or pass drug use.

Who the study is looking for

  • At least one core clinical feature of dementia with Lewy bodies such as visual hallucinations, parkinsonism, cognitive fluctuations, or probable REM sleep behaviour disorder.

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Karolinska University Hospital
Coordinator of this site? Confirm its status
StockholmSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.